Second-generation antihistamines are unquestionably the first-line treatment for chronic urticaria and can be used at higher than licensed doses if normal doses fail to control the disease. A short course of oral corticosteroids should be considered for patients not responding to antihistamines before trying other immunosuppressive drugs. Ciclosporin is effective in most antihistamine-resistant patients who require long-term corticosteroid treatments to control their disease. Omalizumab is effective in most subsets of chronic urticaria sufferers who do not respond to other treatments but its high cost represents a limitation to its widespread use. © 2014 Elsevier Inc.

Treatment of Chronic Urticaria / R. Asero, A. Tedeschi, M. Cugno. - In: IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA. - ISSN 0889-8561. - 34:1(2014 Feb), pp. 105-116. [10.1016/j.iac.2013.09.013]

Treatment of Chronic Urticaria

M. Cugno
Ultimo
2014

Abstract

Second-generation antihistamines are unquestionably the first-line treatment for chronic urticaria and can be used at higher than licensed doses if normal doses fail to control the disease. A short course of oral corticosteroids should be considered for patients not responding to antihistamines before trying other immunosuppressive drugs. Ciclosporin is effective in most antihistamine-resistant patients who require long-term corticosteroid treatments to control their disease. Omalizumab is effective in most subsets of chronic urticaria sufferers who do not respond to other treatments but its high cost represents a limitation to its widespread use. © 2014 Elsevier Inc.
Antihistamines; Chronic urticaria; Ciclosporin; Corticosteroids; Omalizumab; Therapy; Chronic Disease; Humans; Urticaria; Immunology and Allergy; Immunology
Settore MED/09 - Medicina Interna
feb-2014
28-ott-2013
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/340290
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 12
social impact